A Novel Cuproptosis-Associated Gene Signature to Predict Prognosis in Patients with Pancreatic Cancer

Figure 4

The differences in survival time of PAAD patients between high- and low-risk groups. The OS time KM curve in the training group (a), validation group (b), and entire cohort (c). The PFS time KM curve in the training group (d), validation group (e), and entire cohort (f). The DSS time KM curve in the training group (g), validation group (h), and entire cohort (i). The differences between the high- and low-risk groups were measured by log rank. PAAD: pancreatic cancer; KM: Kaplan-Meier; OS: overall survival; PFS: progression-free survival; DSS: disease-specific survival.